Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -46.30 is 99% above its 5-year average of -5539.80, near the high end of its 5-year range (-21853.30–-46.30).
79.59% above its 12-month average of -226.80.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -12.35.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 20 comparable quarters.
EARNINGS PER SHARE (EPS)
-46.30
EARNINGS PER SHARE (EPS) AVG TTM
-226.80
EARNINGS PER SHARE (EPS) AVG 3Y
-2352.88
EARNINGS PER SHARE (EPS) AVG 5Y
-5539.80
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+79.59%
CURRENT VS 3Y AVG
+98.03%
CURRENT VS 5Y AVG
+99.16%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Tenon Medical, Inc.
Market Cap
$1.84M
Earnings Per Share (EPS)
-46.30
TTM Avg
-226.80
3Y Avg
-2352.88
5Y Avg
-5539.80
Market Cap
$1.84M
Earnings Per Share (EPS)
-53.60
TTM Avg
-139.70
3Y Avg
-437.70
5Y Avg
-488.64
Market Cap
$1.83M
Earnings Per Share (EPS)
-213.25
TTM Avg
-232.07
3Y Avg
-150.88
5Y Avg
-127.10
Market Cap
$1.81M
Earnings Per Share (EPS)
-1.95
TTM Avg
-2.56
3Y Avg
-13.27
5Y Avg
-27.21
Market Cap
$1.88M
Earnings Per Share (EPS)
-50.69
TTM Avg
-49.87
3Y Avg
-19185.19
5Y Avg
-12947.08
Market Cap
$1.88M
Earnings Per Share (EPS)
-46.49
TTM Avg
-92.15
3Y Avg
-143.14
5Y Avg
-171.91
Market Cap
$1.64M
Earnings Per Share (EPS)
-5.35
TTM Avg
-12.67
3Y Avg
-17.25
5Y Avg
-14.07
Market Cap
$2.13M
Earnings Per Share (EPS)
-13.89
TTM Avg
-71.45
3Y Avg
-134.10
5Y Avg
-124.65
Market Cap
$2.14M
Earnings Per Share (EPS)
-2.06
TTM Avg
-2.14
3Y Avg
-10.33
5Y Avg
-14.99
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tenon Medical, Inc. (TNON) | $1.84M | -46.30 | -226.80 | -2352.88 | -5539.80 |
| Beyond Air, Inc. (XAIR)vs › | $1.84M | -53.60 | -139.70 | -437.70 | -488.64 |
| Profusa, Inc. Common Stock (PFSA)vs › | $1.83M | -213.25 | -232.07 | -150.88 | -127.10 |
| Alaunos Therapeutics, Inc. (TCRT)vs › | $1.81M | -1.95 | -2.56 | -13.27 | -27.21 |
| TransCode Therapeutics, Inc. (RNAZ)vs › | $1.88M | -50.69 | -49.87 | -19185.19 | -12947.08 |
| Autonomix Medical, Inc. (AMIX)vs › | $1.88M | -46.49 | -92.15 | -143.14 | -171.91 |
| Silo Pharma, Inc. (SILO)vs › | $1.64M | -5.35 | -12.67 | -17.25 | -14.07 |
| GeoVax Labs, Inc. (GOVX)vs › | $2.13M | -13.89 | -71.45 | -134.10 | -124.65 |
| Vivos Therapeutics, Inc. (VVOS)vs › | $2.14M | -2.06 | -2.14 | -10.33 | -14.99 |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.52M | -10.02 | -4.85 | -7.18 | -7.18 |
Trailing EPS (TTM)
$-46.30
Forward EPS (Est.)
$-21.25
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -59.50 |
| 2024-12-31 | -394.10 |
| 2023-12-31 | -2402.40 |
| 2022-12-31 | -6555.50 |
| 2021-12-31 | -21853.30 |
| 2020-12-31 | -1974.00 |
| 2019-12-31 | -1719.20 |
